ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
62,679.61
-1.66%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) News

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVXL
DateTimeSourceHeadlineSymbolCompany
04/26/20244:45AMPR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/19/20244:45AMPR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
04/16/20244:45AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/12/20244:45AMPR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
04/11/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
04/09/20244:45AMPR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
04/05/20244:45AMPR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
04/02/20244:45AMPR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
03/29/20244:45AMPR Newswire (US)Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
03/26/20244:45AMPR Newswire (US)Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
03/25/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
03/22/20244:45AMPR Newswire (US)AVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:AVXLAnavex Life Sciences Corporation
03/18/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
02/26/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20245:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20245:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20245:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20245:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/23/20245:03AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
02/07/20243:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
02/07/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
02/01/20246:30AMGlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
01/25/20244:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVXLAnavex Life Sciences Corporation
01/24/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in HumansNASDAQ:AVXLAnavex Life Sciences Corporation
01/16/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
01/12/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
01/08/20246:30AMGlobeNewswire Inc.Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental DisordersNASDAQ:AVXLAnavex Life Sciences Corporation
01/03/20246:30AMGlobeNewswire Inc.Anavex to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
01/02/20247:00AMGlobeNewswire Inc.Anavex Life Sciences Provides an Update on Rett Syndrome ProgramNASDAQ:AVXLAnavex Life Sciences Corporation
12/20/20236:30AMGlobeNewswire Inc.Anavex Announces First Entire Clinical Gene Pathway Data of ANAVEX®2-73 from AVATAR Study in Patients with Rett SyndromeNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL

Your Recent History

USOTC
CBIA
Canopus Biopharma (PK)
USOTC
TDRK
TideRock Companies (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
SBFM
Sunshine Biopharma
USOTC
ACRL
Atacama Resources (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
CEOS
CeCors (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
AXXA
Exxe (PK)
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved